View Older Stories View More Recent Stories

Jul 15, 2014 09:27AM No Major N-T Impact Expected on Solars Following WTO Statement on U.S. Antidumping Duties - Roth (SCTY) (JASO) (TSL) (YGE)
Jul 11, 2014 08:35AM Roth Affirms Verastem (VSTM) at 'Buy'; Encouraged by VS-6063's Potential in Mesothelioma, Ovarian Cancer
Jul 11, 2014 08:23AM Tonix Pharmaceuticals (TNXP) Enters 657K Direct Placement at $11.90/Share
Jul 11, 2014 08:12AM Roth Capital Downgrades Golden Minerals Company (AUMN) to Neutral
Jul 10, 2014 12:09PM Streetinsider.com's Hot Lunchtime Reads 07/10: (CYNK) (MSFT) (SRPT) (CYTK)
Jul 10, 2014 11:14AM Roth Capital Keeps Cytokinetics (CYTK) at 'Buy' Following Recent BENEFIT-ALS Update
Jul 10, 2014 08:29AM Roth Capital Affirms Regeneron (REGN) at 'Buy' Following Positive Dupilumab Phase 2b Update
Jul 9, 2014 05:14PM RGS Energy (RGSE) Closes 2.92M Equity Offering at $2.40/Share
Jul 9, 2014 05:00PM RGS Energy Completes $7.0 Million Private Equity Offering
Jul 9, 2014 01:21PM PlacementTracker Publishes First Half 2014 PIPE Market League Tables
Jul 8, 2014 12:07PM Streetinsider.com's Hot Lunchtime Reads 07/08: (PETM) (AAPL) (CNCE) (MSFT)
Jul 8, 2014 10:30AM Roth Capital Keeps Concert Pharma (CNCE) at 'Buy'; SPA Filing is Sign of Confidence in CTP-499
Jul 7, 2014 09:48AM Roth Capital Starts PTC Therapeutics (PTCT) at Buy
Jul 7, 2014 09:36AM Roth Capital 'Encouraged' by Notice of Intent in Cytori's (CYTX) Contract with BARDA
Jul 7, 2014 07:20AM Roth Capital Remains Positive on Spectrum Pharma (SPPI) as Beleodaq Wins Accelerated Approval
Jul 3, 2014 07:47AM RGS Energy (RGSE) Prices $7M Equity Raise
Jul 3, 2014 07:45AM RGS Energy Prices Equity Offering
Jul 2, 2014 09:27AM Roth Reinstates BioLineRx (BLRX) at 'Buy'; Strong Pipeline Reinforces Upside Potential
Jul 2, 2014 08:44AM Roth Capital Resumes BioLineRx (BLRX) at Buy
Jun 29, 2014 02:41AM Medigus Announces Signing of $11.1 Million Private Placement by Leading Israeli and U.S. Institutions
Jun 27, 2014 09:06AM Roth Capital Remains Positive on Stemline (STML); Management Updates on SL-401, SL-701
Jun 27, 2014 08:05AM IGI Labs (IG) Prices 4.65M Common Offering at $5 Apiece
Jun 27, 2014 06:51AM Roth Capital Starts Dot Hill (HILL) at Buy
Jun 26, 2014 04:09PM IGI Laboratories (IG) Annouces Stock Offering
Jun 26, 2014 07:52AM Slow Ramp Leaves R-22 Pricing Flat; Roth Keeps Hudson Tech (HDSN) at 'Buy'
Jun 25, 2014 03:42PM Roth Capital Keeps LIgand Pharma (LGND) at Buy; Glaxo Initiates Promacta Phase III
Jun 25, 2014 08:57AM Wunderlich Expands into Consumer and Business Services Investment Banking
Jun 25, 2014 06:39AM Roth Capital Starts Concur Technologies (CNQR) at Buy
Jun 24, 2014 09:34AM Roth 'Encouraged' by TG Therapeutics (TGTX), Ligand (LGND) Deal; Issues Commentary
Jun 24, 2014 06:58AM Roth Affirms Hydrogenics (HYGS) at Buy; JV with Kolon Water is Step in Right Direction
Jun 23, 2014 12:04PM Streetinsider.com's Hot Lunchtime Reads 06/23: (MSFT) (LGND) (RSH) (YELP)
Jun 23, 2014 11:28AM Roth Capital Comments on New SERM Lasofoxifene Phase 1 Data
Jun 20, 2014 01:04PM Unusual 11 Mid-Day Movers 06/20: (KMX) (FLML) (CARA) Higher; (MACK) (PVCT) (CLRX) Lower
Jun 18, 2014 12:29PM SolarCity (SCTY) Continues Higher Following Silevo Deal, Management Commentary
Jun 18, 2014 07:14AM Roth Capital Starts Prosensa (RNA) at Neutral
Jun 18, 2014 06:51AM Roth Capital Starts Superior Drilling Products (SDPI) at Buy
Jun 18, 2014 06:19AM Roth Boosts Target on SolarCity (SCTY) to $80; Silevo Acquisition 'Makes Sense'
Jun 17, 2014 04:16PM Yingli Green Energy (YGE) Could See H214 Ramp; Roth Capital Keeps at 'Neutral'
Jun 17, 2014 12:36PM Roth 'Impressed' at Early Completion of Enrollment in Galena's (GALE) GALE-301 Phase 2a; Keeps at 'Buy'
Jun 17, 2014 08:54AM UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital
Jun 16, 2014 10:28AM LGD-6972 Could Drive Partnership; Roth Keeps Ligand Pharma (LGND) at 'Buy'
Jun 13, 2014 11:20AM New Promacta Data Should Support Approval for cITP; Roth has Ligand (LGND) at 'Buy'
Jun 13, 2014 11:13AM Roth 'Encouraged' by TG Therapeutics' (TGTX) TG-1101 Phase 2 Prelim Results; Boosts PT to $20
Jun 13, 2014 10:33AM Notable Analyst Rating Changes 06/13: (INTC) (GEF) (NMBL) Upgraded; (MRVL) (LULU) (MRO) Downgraded
Jun 13, 2014 09:30AM Pre-Open Stock Movers 6/13: (OPEN) (EXPR) (ICLD) Higher; (FNSR) (OCLS) (ETRM) Lower (more...)
Jun 13, 2014 09:22AM Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy
Jun 13, 2014 06:39AM Roth Capital Upgrades Intel (INTC) to Buy
Jun 13, 2014 06:37AM Roth Capital Starts Fusion-io (FIO) at Buy
Jun 13, 2014 06:35AM Worst of Capstone Turbine (CPST) Probably Priced in; Roth Affirms 'Buy' Rating
Jun 12, 2014 11:10AM Roth Comments on Regeneron (REGN), Sanofi Presentation of Sarilumab Phase 3 Data; Affirms at 'Buy'
View More Recent Stories View Older Stories